We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active

Road-to-Market Study for 9 countries

Market access, pricing and reimbursement, and market intelligence insights on 9 countries
Market access, pricing and reimbursement, and market intelligence insights on 9 countries
Global consulting firm
9 CIS, South Caucasian & Central Asian countries
Promotion study:
  • Study of measures regulating sales and marketing activities established in each country.
  • Overview of general regulatory environments concerning promotional activities by pharmaceutical companies.
Demand forming study:
  • Overview of approaches of demand forming per each country.
  • Analysis of general strategies in hospital and retail segments aimed to form a demand at a particular level.
  • Country-specific critical success factors in developing business in state-funded and out-of-pocket segments.
  • Market Access & Reimbursement detailed step-by-step roadmap.
  • Overview of all procedures concerning bringing a pharmaceutical market to hospital and retail consumers.
Reimbursement study:
  • Analysis of how the reimbursement model work in each country.
  • Identifying critical drivers makes an individual product qualify as a drug for reimbursement.
Pricing study:
  • Analysis of price regulations for hospital and retail segments.
  • Overview of price forming mechanisms, price mark-ups etc.
  • Identification of crucial price-forming factors per each supply chain segment.
  • Analysis of established pricing policies in public purchases.
  • Overview of general cost-containment measures and price reduction mechanisms induced by local governments.
Formulary study:
  • Mapping stakeholders in the formulary system in each country.
  • Outlining the scheme of the formulary enlisting process.
  • Review of the regulatory environment in each country's formulary system.
  • Identification of national formulary commission members.
Public purchases/ state tenders study:
  • Building-up tender architectures for each country in focus.
  • Identifying products and therapeutic areas that are the primary focus for public purchases in each country.
  • Outlining the mechanisms and processes concerning participation in public purchases.
  • Analysis of preferential conditions for local manufacturers per each country.
  • Analysis of the regulatory environment in public purchases.
  • Outlining stakeholders in public purchases.
Project areas:
  • Price regulation measures and other essential regulations.
  • Analysis of business models utilized in each country in focus.
  • Pricing & Reimbursement landscapes.
  • National formulary systems.
  • Demand forming activities analysis.
  • Supply chain stakeholders overview.
  • Overview of the regulatory framework in market access and marketing authorization.
  • Summary of recent regulatory changes on the road-to-market pathway in each country.
Market analysis:
  • Outlining all key players across the pharmaceutical supply chain per country.
  • Analysis of online pharmacy channels where available.
  • Market analysis by segments: gastrointestinal, oncology, musculoskeletal, and aesthetics.
  • Analysis of market channels: retail, hospital (public tenders), and online (where available).
Business model analysis:
  • Identification of key success factors, decision-making processes, and decision criteria for OTC and Rx products per country.
  • Study of successful OTC product strategy examples per country.
  • Analysis of differences between wholesalers/distributors in each market regarding services they provide and supply chain infrastructure.
  • Understanding terms and conditions in partnerships with distributors and wholesalers.
  • Study of established practices of partnering with local pharmacy chains.
  • Elaboration of best practices for salesforce setup: team size and visiting frequency, team cost, etc.
  • Outlining roles of prescribers, HCPs, GPs, and pharmacists per type of drug per country.
  • Finding out key organizational capabilities to be successful in each market.
  • Study of "go-to-market" and marketing approaches in all countries.


Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
Anastasiia Maksymenko
Co-founder, Recruitment Partner (Pharma, Biotechnology, MedTech, Healthcare)
our Brochure